Unisphere Establishment’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$97.7M Buy
+605,000
New +$101M 0.82% 25

Other funds holding AZN

Unisphere Establishment's AZN Position: Q3 2026 in Review

Unisphere Establishment opened a new position in AstraZeneca (AZN) in Q3 2026: 605,000 shares worth $97.7M. The stake represents 0.82% of the portfolio and ranks #25 among its holdings.

1,443 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Unisphere Establishment held 605,000 shares of AstraZeneca worth $97.7M as of Q3 2026.
  • AstraZeneca was a new Unisphere Establishment position in Q3 2026.
  • AstraZeneca made up 0.82% of Unisphere Establishment's portfolio in Q3 2026, its #25 holding.
  • 1,443 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Unisphere Establishment's 13F filing for Q3 2026, filed 16 Nov 2026.